Skip to content

Dynamic changes of Intestinal microecology in HBV patients with peginterferon with low HBsAg level

Dynamic changes of Intestinal microecology in HBV patients with peginterferon with low HBsAg level

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020418
Enrollment
Unknown
Registered
2018-12-29
Start date
2019-01-02
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Case series:Nil

Sponsors

The Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of chronic hepatitis B; 2. Aged 18-60 years old; 3. NAs treatment for more than 1 year, currently HBsAg=1500 IU/ml, HBeAg-negative and HBV DNA<100 IU/ml; 4. No interferon treatment contraindications, willing to receive PEG-IFN treatment and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Interferon allergic; 2. ALT is greater than 10 times the upper limit of normal, total bilirubin is greater than 2 times the upper limit of normal; 3. Decompensated cirrhosis, or cirrhosis decompensation; 4. Peripheral blood leukocyte count and / or platelet count is lower than the normal limit; 5. There are serious important organs such as cardiovascular, lung, kidney, brain lesions and fundus lesions; 6. Patients with autoimmune diseases, mental illness, diabetes, thyroid dysfunction (hyperactivity or low); 7. Patients diagnosed or suspected of liver cancer and other malignant tumors; 8. After organ transplantation or preparation for organ transplant; 9. Those who are using immunosuppressants; 10. Pregnancy or planned pregnancy within 2 years; 11. Alcohol or drug addicts; 12. Consolidation of people living with HIV; 13. The competent doctor considers that there are other situations in which interferon should not be used; 14. Patients with chronic diarrhea or patients with acute diarrhea in the last week; 15. There are cases where long-term oral antibiotics need to be taken or not undergoing intestinal metabolism in combination with other infections or diseases.

Design outcomes

Primary

MeasureTime frame
Intestinal microecology;

Contacts

Public ContactMo Zhi-shuo

The Third Affiliated Hospital of Sun Yat-sen University

vbstone@126.com+86 13632434363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026